SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed Ajootian who wrote (2172)3/28/1999 3:31:00 PM
From: David Howe  Read Replies (2) of 10280
 
From Sepracor's web site. Not sure how up to date it is.

Dave

<< Sepracor has recently completed the fall Phase III Seasonal Allergic Rhinitis (SAR) study as well as the Phase III Environmental Exposure Unit (ERM study of norastemizole and is awaiting trial results.) >>

The link to the full report on Norastemizole.

sepracor.com

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext